On November 4, Centene rose 6.09% in Regular Trading, trading at $71.33 per share, with turnover of $158.0 million.
The clearest catalyst was a fresh round of analyst target-price increases. On November 2, Truist raised its target on Centene to $82 from $80 and maintained a buy rating, following UBS on October 28 raising its target to $78 from $70.
The broader backdrop includes stronger-than-expected operating results disclosed on October 27 for the quarter ended September, when Centene reported EPS of $0.58. Earlier, the company had reported second-quarter adjusted EPS of $2.51 and revenue of $53.579 billion, both above expectations, while guiding for full-year adjusted EPS above $4.80. At the same time, investors have also been monitoring membership growth and restructuring costs tied to a voluntary separation plan, which provide context for the market's focus on execution and profit recovery.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments